Target Price | $28.56 |
Price | $23.87 |
Potential |
19.65%
register free of charge
|
Number of Estimates | 25 |
25 Analysts have issued a price target Pfizer 2026 .
The average Pfizer target price is $28.56.
This is
19.65%
register free of charge
$43.56
82.51%
register free of charge
$24.24
1.55%
register free of charge
|
|
A rating was issued by 30 analysts: 13 Analysts recommend Pfizer to buy, 16 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Pfizer stock has an average upside potential 2026 of
19.65%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 63.63 | 63.88 |
6.84% | 0.39% | |
EBITDA Margin | 34.60% | 40.35% |
15.57% | 16.62% | |
Net Margin | 12.62% | 27.75% |
254.74% | 119.85% |
24 Analysts have issued a sales forecast Pfizer 2025 . The average Pfizer sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Pfizer EBITDA forecast 2025. The average Pfizer EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Pfizer Analysts have issued a net profit forecast 2025. The average Pfizer net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.41 | 3.12 |
281.08% | 121.28% | |
P/E | 7.66 | |
EV/Sales | 2.88 |
24 Analysts have issued a Pfizer forecast for earnings per share. The average Pfizer EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 22 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
Analyst Rating | Date |
---|---|
Locked
B of A Securities:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 22 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.